These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 21030245)

  • 21. Heterologous production of 4-O-demethylbarbamide, a marine cyanobacterial natural product.
    Kim EJ; Lee JH; Choi H; Pereira AR; Ban YH; Yoo YJ; Kim E; Park JW; Sherman DH; Gerwick WH; Yoon YJ
    Org Lett; 2012 Dec; 14(23):5824-7. PubMed ID: 23148802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Marine Pseudovibrio sp. as a novel source of antimicrobials.
    Crowley SP; O'Gara F; O'Sullivan O; Cotter PD; Dobson AD
    Mar Drugs; 2014 Dec; 12(12):5916-29. PubMed ID: 25501794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Marine natural products as a source of novel pharmacological agents.
    Carté BK
    Curr Opin Biotechnol; 1993 Jun; 4(3):275-9. PubMed ID: 7764057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biosynthetic origin of natural products isolated from marine microorganism-invertebrate assemblages.
    Simmons TL; Coates RC; Clark BR; Engene N; Gonzalez D; Esquenazi E; Dorrestein PC; Gerwick WH
    Proc Natl Acad Sci U S A; 2008 Mar; 105(12):4587-94. PubMed ID: 18250337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A review of pharmacological and toxicological potentials of marine cyanobacterial metabolites.
    Nagarajan M; Maruthanayagam V; Sundararaman M
    J Appl Toxicol; 2012 Mar; 32(3):153-85. PubMed ID: 21910132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential therapeutic agents from the red sea organisms.
    Alam MA
    Med Chem; 2014; 10(6):550-63. PubMed ID: 24364824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrating mass spectrometry and genomics for cyanobacterial metabolite discovery.
    Moss NA; Bertin MJ; Kleigrewe K; Leão TF; Gerwick L; Gerwick WH
    J Ind Microbiol Biotechnol; 2016 Mar; 43(2-3):313-24. PubMed ID: 26578313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Manzamines: a potential for novel cures.
    Radwan M; Hanora A; Khalifa S; Abou-El-Ela SH
    Cell Cycle; 2012 May; 11(9):1765-72. PubMed ID: 22510565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Marine Cyanobacteria as Sources of Lead Anticancer Compounds: A Review of Families of Metabolites with Cytotoxic, Antiproliferative, and Antineoplastic Effects.
    Robles-Bañuelos B; Durán-Riveroll LM; Rangel-López E; Pérez-López HI; González-Maya L
    Molecules; 2022 Jul; 27(15):. PubMed ID: 35956762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Marine Cyanobacteria: A Source of Lead Compounds and their Clinically-Relevant Molecular Targets.
    Tan LT; Phyo MY
    Molecules; 2020 May; 25(9):. PubMed ID: 32397127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural Diversity, Biological Properties and Applications of Natural Products from Cyanobacteria. A Review.
    Shah SAA; Akhter N; Auckloo BN; Khan I; Lu Y; Wang K; Wu B; Guo YW
    Mar Drugs; 2017 Nov; 15(11):. PubMed ID: 29125580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Collection, Culturing, and Genome Analyses of Tropical Marine Filamentous Benthic Cyanobacteria.
    Moss NA; Leao T; Glukhov E; Gerwick L; Gerwick WH
    Methods Enzymol; 2018; 604():3-43. PubMed ID: 29779657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Marine-derived Aspergillus species as a source of bioactive secondary metabolites.
    Lee YM; Kim MJ; Li H; Zhang P; Bao B; Lee KJ; Jung JH
    Mar Biotechnol (NY); 2013 Oct; 15(5):499-519. PubMed ID: 23709045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apple Pomace as Potential Source of Natural Active Compounds.
    Waldbauer K; McKinnon R; Kopp B
    Planta Med; 2017 Aug; 83(12-13):994-1010. PubMed ID: 28701021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Marine
    Li H; Fu Y; Song F
    Mar Drugs; 2023 Apr; 21(5):. PubMed ID: 37233471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Secondary Metabolites from Polar Organisms.
    Tian Y; Li YL; Zhao FC
    Mar Drugs; 2017 Feb; 15(3):. PubMed ID: 28241505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tiny Microbes with a Big Impact: The Role of Cyanobacteria and Their Metabolites in Shaping Our Future.
    Mazard S; Penesyan A; Ostrowski M; Paulsen IT; Egan S
    Mar Drugs; 2016 May; 14(5):. PubMed ID: 27196915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New anticancer drugs from marine cyanobacteria.
    Russo P; Cesario A
    Curr Drug Targets; 2012 Jul; 13(8):1048-53. PubMed ID: 22594472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immense essence of excellence: marine microbial bioactive compounds.
    Bhatnagar I; Kim SK
    Mar Drugs; 2010 Oct; 8(10):2673-701. PubMed ID: 21116414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Review of Anti-Inflammatory Compounds from Marine Fungi, 2000-2018.
    Xu J; Yi M; Ding L; He S
    Mar Drugs; 2019 Nov; 17(11):. PubMed ID: 31717541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.